Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors

International Journal of Gynecology and Obstetrics

Volumn 55, Issue 3, 1996, Pages 273-279

  Abdel Aleem, H ^a   Ahmed, A ^a   Sabra, A M ^a   Zakhari, Madeha ^a   Soliman, M ^a   Hamed, H ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

Malignant ovarian tumors; Tumor markers; L Fucosidase

Indexed keywords

ALPHA LEVO FUCOSIDASE; CA 125 ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; MAJOR CLINICAL STUDY; OVARY TUMOR; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VULVA CARCINOMA;

EID: 0030462046     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(96)02770-1     Document Type: Article

References (11)

1. [1] Barlow JJ, Dicioccio RA, Dillaro PH et al. Frequency of allele for low activity of α-L-fucosidase in sera: possible increase in epithelial ovarian cancer patients. J Natl Cancer Inst 1981; 67: 1005-1009.
2. [2] Lynch HT, Schuelke GS, Wells JC et al. Hereditary ovarian carcinoma: biomarker studies. Cancer 1985; 55: 410-415.
3. [3] Barber HRK. New frontiers in ovarian cancer diagnosis and management. Yale J Biol Med 1991; 64: 127-141.
4. [4] Schwartz PE, Toylor KIW. Screening for ovarian cancer. In: Rock JA, editor. Advances in obstetrics and gynecology, Vol. 2. St. Louis, MO: Mosby-Year Book, 1995; 261-284.
5. [5] Muto MS, Cramer DN, Brown DL et al. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center. Gynecol Oncol 1993; 51: 12-20.
6. [6] Giardina MG, Matarazzo M, Varriale A, Morante R, Napoli A, Martino R. Serum α-L-fucosidase a useful marker in the diagnosis of hepatocellular carcinoma. Cancer 1992; 70: 1044-1048.
7. [7] Zielke K, Okada S, O'Brien J. Fucosidosis, diagnosis by serum assay of α-L-fucosidase. J Lab Clin Med 1972; 19: 164-169.
8. [8] Bast RC Jr et al. Reactivity of monoclonal antibody with human ovarian carcinoma [abstract]. Proc Ann Cancer Res 1980; 21: 207.
9. [9] Wells IC, Lynch HT and Lynch JF. α-L-Fucosidase variant and lipid-associated sialic acid in hereditary ovarian cancer. Cancer Genet Cytogenet 1987; 25: 247-251.
10. [10] Bast RC Jr, Klug TL, Schaetzl E et al. Monitoring human ovarian carcinoma with a combination of CA125, CA19-9 and carcinombryonic antigen. Am J Obstet Gynecol 1984; 149: 553.
11. [11] Li XE, Chen DX, Schwartz PE et al. A study of the monoclonal antibody OC 125 to diagnose malignant ovarian tumors. Gynecol Oncol 1989; 32: 327-330.